NCT07048938

Brief Summary

The goal of this clinical trial is to learn if Five-Elements Music Therapy works to treat depression disorder. It will also learn about the mechanism of action of Five-Elements Music Therapy of Traditional Chinese Medicine (TCM) for depression disorder. The main questions it aims to answer is: Can Five-Elements Music Therapy, primarily using Gong-mode and Zhi-mode tones, improve Hamilton Depression Rating Scale (HAMD) scale scores in patients with depression disorder by regulating prefrontal cortex function? Researchers will compare customized five-element music 1 (featuring Gong-mode and Zhi-mode as the predominant tones) to customized five-element music 2 (featuring Shang-mode and Yu-mode as the predominant tones, with identical rhythm and pitch to music 1), while simultaneously observing electroencephalogram (EEG), eye movement, and pulse diagnostic data from a healthy control group, to see if customized five-element music 1 featuring Gong-mode and Zhi-mode as the predominant tones can significantly improve depressive states in patients with depressive disorder. Participants will:

  1. 1.Undergo Five-Element Music 1 or Five-Element Music 2 therapy twice daily for 4 weeks (28 days), with each session consisting of 30 minutes of music listening followed by 10 minutes of rest.
  2. 2.Concurrently receive antidepressant therapy with fluoxetine hydrochloride.
  3. 3.Undergo relevant examinations once every two weeks and record their levels of depression and anxiety (Hamilton Depression Rating Scale (HAMD) \& Hamilton Anxiety Rating Scale (HAMA)).
  4. 4.Undergo and record their post-intervention electroencephalogram (EEG), eye movement, and pulse characteristics after the 4-week period.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 3, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

6 months

First QC Date

June 12, 2025

Last Update Submit

June 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The reduction rate of Hamilton Depression Rating Scale-17(HAMD-17) after treatment

    Reduction rate = (Baseline HAMD-17 score - Week 4 HAMD-17 score) / Baseline HAMD-17 score. A HAMD-17 response rate ≥50% is defined as an effective treatment

    From enrollment to the end of the treatment at 4 weeks

Secondary Outcomes (6)

  • Hamilton Anxiety Rating Scale(HAMA)

    From enrollment to the end of treatment at 4 weeks

  • Repeatable Battery for the Assessment of Neuropsychological Status(RBANS)

    From enrollment to the end of treatment at 4 weeks

  • Treatment Emergent Symptom Scale(TESS)

    From enrollment to the end of treatment at 4 weeks

  • Event-related potential(ERP)

    From enrollment to the end of treatment at 4 weeks

  • Eye Movement(EM)

    From enrollment to the end of treatment at 4 weeks

  • +1 more secondary outcomes

Study Arms (3)

Five-Element Music 1 Primarily in Gong and Zhi modes combined with antidepressant medication

EXPERIMENTAL
Combination Product: Five-Element Music 1 combined with antidepressant medication

Five-Element Music 2 Primarily in Shang and Yu modes combined with antidepressant medication

ACTIVE COMPARATOR
Combination Product: Five-Element Music 2 combined with antidepressant medication

health control

OTHER
Other: No Intervention: Observational Cohort

Interventions

The self-composed musical piece Five Elements Music 1 was selected to intervene with the patients, with the songs primarily based on the Gong tone and Zhi tone in traditional Chinese music. On this basis, the intervention was combined with fluoxetine hydrochloride treatment

Five-Element Music 1 Primarily in Gong and Zhi modes combined with antidepressant medication

The self-composed musical piece Five Elements Music 2 was selected to intervene with the patients, with the songs primarily based on the Shang mode (A) and Yu (E) mode in traditional Chinese music. On this basis, the intervention was combined with fluoxetine hydrochloride treatment

Five-Element Music 2 Primarily in Shang and Yu modes combined with antidepressant medication

No intervention will be applied to healthy people

health control

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Meet the diagnostic criteria for depressive episodes of ICD-10;
  • Hamilton Depression Scale -17 items score ≥14 points;
  • The diagnosis should be confirmed by at least two physicians with the title of attending physician or above.
  • Have sufficient visual and auditory levels to ensure that the necessary checks and experiments for the research can be completed;
  • Sign the written informed consent form and agree to be enrolled in the trial as required by the research plan.

You may not qualify if:

  • There are serious heart, liver and kidney diseases, organic brain diseases, serious cardiovascular diseases, tumors, blood history, rheumatism, malnutrition and neurodegenerative diseases, etc.
  • Depressive episodes secondary to other mental or physical illnesses;
  • There is a history of abuse of tobacco, alcohol and other psychoactive substances;
  • Those with comorbidities of other mental disorders;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depressive Disorder

Interventions

Antidepressive Agents

Condition Hierarchy (Ancestors)

Mood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Psychotropic DrugsCentral Nervous System AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2025

First Posted

July 3, 2025

Study Start

July 1, 2025

Primary Completion

December 31, 2025

Study Completion

March 31, 2026

Last Updated

July 3, 2025

Record last verified: 2025-06